Acute myeloid leukemia (AML) is a highly aggressive and difficult-to-treat blood cancer. This study explores the role of ...

Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at ...

highlighting concentrated regions of diverse and interacting immune cells present pre-treatment (left) and an increase in numbers of T cells with treatment (right). AML, which affects four out of ...

Subscribe for FREE For patients with AML, a stem cell transplant holds the potential for a cure. The goal of the transplant is to replace the patient’s hematopoietic stem cells – cells that rejuvenate ...

Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells. Inflammatory cytokines like IFN-γ and TNF-α are key contributors to immune ...

TuHURA will pursue an indication in AML, where there is evidence of a signal ... These proteins stimulate an innate immune response which destroys cancer cells and subsequently activates an ...